Cigna Corporation
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, …
Medical - Healthcare Plans
US, Bloomfield [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -46.93 | -57.37 | 108.11 | |
| Graham Fair Price | -50.00 | 55.93 | 111.84 | |
| PEG | 8272.07 | 0.74 | < 0.005 | |
| Price/Book | 33.65 | 2.53 | 1.89 | |
| Price/Cash Flow | -71.10 | 22.97 | 79.48 | |
| Prices/Earnings | 342.33 | -94.13 | 21.28 | |
| Price/Sales | 9.75 | 1.88 | 1.71 | |
| Price/FCF | -71.10 | 22.97 | 79.48 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 1.39 | 0.83 | 0.82 | |
| Operating Margin | 102.08 | 0.04 | 0.02 | |
| ROA | -73.18 | < 0.005 | < 0.005 | |
| ROE | 0.02 | < 0.005 | -69.78 | |
| ROIC | 0.08 | -0.08 | 4.38 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.04 | 0.01 | 274.73 | |
| Dividends QOQ | < 0.005 | 0.14 | 2379.86 | |
| EBIT QOQ | -0.54 | 1.19 | 120.56 | |
| EPS QOQ | 24.14 | -1.28 | -94.72 | |
| FCF QOQ | -0.55 | 3.12 | 472.24 | |
| Revenue QOQ | 0.04 | 0.08 | 105.04 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Positive
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 54.75 | 44.14 | -19.37 | |
| Days Sales Outstanding (DSO) | 41.72 | 40.98 | -1.77 | |
| Inventory Turnover | 1.64 | 2.04 | 24.02 | |
| Debt/Capitalization | 0.40 | 0.44 | 10.34 | |
| Quick Ratio | 0.67 | 0.67 | 0.54 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 158.03 | 143.76 | -9.03 | |
| Cash | 29.90 | 33.33 | 11.45 | |
| Capex | -1.25 | -1.05 | 16.08 | |
| Free Cash Flow | 3.77 | 15.85 | 320.66 | |
| Revenue | 174.63 | 193.46 | 10.78 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Best
Fundamentals
Financial Health
06 - Financial Health ·
Bad